Daniels Eric Joseph
SEC insider (Form 3/4/5 filer). CIK 0001892943. Chief Development Officer at PLUS THERAPEUTICS, INC. (PSTV) and 1 other issuer. 6 reported Form 4/5 transactions since Sep 2024; latest on Apr 20, 2026. Located in ENCINITAS, CA.
Companies Daniels Eric Joseph has filed insider reports for
- PLUS THERAPEUTICS, INC. (PSTV): Officer, Chief Development Officer
- KIORA PHARMACEUTICALS INC (KPRX): Officer, Chief Development Officer
Daniels Eric Joseph
CIK: 0001892943
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Apr 20, 2026PSTV
PLUS THERAPEUTICS, INC.
AwardDirectRestricted Stock Units
20K shares- - Apr 20, 2026PSTV
PLUS THERAPEUTICS, INC.
AwardDirectStock Option (Right to Buy)
20K shares- - Apr 1, 2026KPRX
KIORA PHARMACEUTICALS INC
Tax PaymentDirect929 shares at avg. $1.95$2K - Mar 6, 2026KPRX
KIORA PHARMACEUTICALS INC
AwardDirect6.5K shares- - Mar 3, 2026KPRX
KIORA PHARMACEUTICALS INC
Tax PaymentDirect238 shares at avg. $2.02$480.76 - Apr 1, 2025KPRX
KIORA PHARMACEUTICALS INC
AwardDirect7.8K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Apr 20, 2026 |  PSTV PLUS THERAPEUTICS, INC. | Award Restricted Stock Units | 20,000 | - | - | Direct |
| Apr 20, 2026 | PSTV PLUS THERAPEUTICS, INC. | Award Stock Option (Right to Buy) | 20,000 | - | - | Direct |
| Apr 1, 2026 |  KPRX KIORA PHARMACEUTICALS INC | Tax Payment | 929 | $1.95 | $1,812 | Direct |
| Mar 6, 2026 | KPRX KIORA PHARMACEUTICALS INC | Award | 6,533 | - | $0 | Direct |
| Mar 3, 2026 | KPRX KIORA PHARMACEUTICALS INC | Tax Payment | 238 | $2.02 | $481 | Direct |
| Apr 1, 2025 | KPRX KIORA PHARMACEUTICALS INC | Award | 7,772 | - | - | Direct |
1-6 of 6 transactions